Editor's Note Robotic-assisted cardiac surgery had significantly reduced length of stay, complications, and mortality compared with nonrobotic surgery in this study. Robotic-assisted had a higher median cost than nonrobotic surgery ($39,030 vs $36,340). The results show that robotic-assisted is as safe as nonrobotic cardiac surgery and offers surgeons an additional…
Editor's Note The use of hybrid coronary revascularization is safe and effective, with faster recovery and similar outcomes compared to conventional coronary artery bypass grafting, this study finds. The 30-day composite of mortality, myocardial infarction, or stroke was similar for both procedures, as was mortality during a 3-year follow-up period.…
Hybrid ORs are proliferating in response to market, surgeon, and even patient demands, but building the business case for this technology can be challenging. “It’s a very expensive proposition,” says Lynne Ingle, MHA, BS, RN, CNOR, project manager for Gene Burton & Associates, a healthcare technology consulting company in Franklin,…
A 65-year-old man with heart disease schedules a knee arthroscopy with his orthopedic surgeon. Thirty miles away, a note pops up to notify the hospital’s presurgical clinic of the impending surgery. A nurse practitioner pulls up the patient’s electronic health record (EHR), where she reviews the patient’s history. Comparing the…